The Department of Defense has selected the last nine awardees for the Distributed Bioindustrial Manufacturing Program, which ...
The BiaB advantages over traditional methods of RNA manufacturing, include high throughput of high-quality pharmaceutical ...
Two years after it was first proposed and a year after it officially launched, the pharma-backed AMR Action Fund has made its first investments in companies trying to tackle the pressing problem ...
The pharma organisation prides itself on having ... conducting remote Good Manufacturing Practice and Good Clinical Practice inspections, and also the acceptance of digital signatures.